Loading insider details...
Beta
Latest Form 4 (Oct 5, 2026): Tax Withholding of 1,047 BBOT shares, $4.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Tax Withholding | 1,047 | $4.1K |
| Sep 15, 2026 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Sale | 2,000 | $15.7K |
| Jul 6, 2026 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Tax Withholding | 1,047 | $8.2K |
| May 21, 2026 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/Award | 3,800 | n/a |
| May 5, 2026 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Tax Withholding | 1,047 | $9.5K |
| Mar 12, 2026 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/Award | 46,670 | n/a |
| Aug 28, 2025 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/Award | 357,177 | n/a |
| Jun 2, 2025 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/Award | 4,800 | n/a |
| Jun 3, 2024 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/Award | 2,783 | n/a |
| May 20, 2024 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/Award | 2,783 | n/a |